National Childhood Vaccine Injury Compensation Act

PEDIATRICS ◽  
1988 ◽  
Vol 82 (2) ◽  
pp. 264-269
Author(s):  
MARTIN H. SMITH

The past four decades have been years of phenomenal progress in all of medicine, yet in terms of numbers of lives saved or in years of productive lives spared, nothing has equaled the record of preventative pediatrics, specifically, our national immunization program. In the past several years, however, this immunization program has almost fallen into shambles. The sources of this reversal would have been from vaccine liability leading to exorbitant costs or loss of supply of vaccines. In the 1970s and 1980s, a series of crises that were only narrowly averted threatened interruption of the national immunization program. It is now worthwhile to trace the events of the past several years so that we can review the continuity of the course of events through those years to understand the necessity for the specific resolution of these problems in the form of the National Childhood Vaccine Injury Compensation Act. The American Academy of Pediatrics played a leading and pivotal role in the long struggle to enact this legislation. It is expected that the act should be the means of avoiding any future threats to our national immunization program through loss of supply. Furthermore, and of equal importance, after time for stabilization and experience with its administration, the act should reduce the cost of vaccines. The courts have dealt with the matter of vaccine injury in an irregular and sometimes unpredictable manner. This legislation should provide a more predictable and just outcome for those few who suffer vaccine injuries. Because this is the first major legislation the Academy has undertaken, the membership should be informed of the time involved in promoting passage of this legislation: the costs in hours by the members, officers, and staff, as well as the monetary costs to the Academy.

PLoS ONE ◽  
2018 ◽  
Vol 13 (7) ◽  
pp. e0201245 ◽  
Author(s):  
Kunling Shen ◽  
Matthew Wasserman ◽  
Dongdong Liu ◽  
Yong-Hong Yang ◽  
Junfeng Yang ◽  
...  

2012 ◽  
Vol 25 (2) ◽  
pp. 145-158 ◽  
Author(s):  
Hye-Young Kang ◽  
Ki Hwan Kim ◽  
Ji Hong Kim ◽  
Hwang Min Kim ◽  
Jinkyung Kim ◽  
...  

The authors assessed the cost-effectiveness of rotavirus vaccination to develop an evidence-based national immunization program in Korea. A Markov model was constructed to compare the costs and clinical outcomes of vaccination versus no vaccination. The birth cohort of 493189 infants in 2007 was followed until the age of 5 years. Korea-specific data for epidemiological characteristics and economic burden of rotavirus diarrhea were used for the modeled estimation. Efficacy of RotaTeq® was based on a recent clinical trial. Rotavirus vaccination would prevent 181238 symptomatic cases (reduction rate = 63.2%) over 5 years after birth. From the societal perspective, at a vaccination cost of 100000 Korean won (KW; 1 US$ ≈ 1200 KW) per dose, universal vaccination would cost 375 620 KW per case averted. The breakeven price of vaccine was 56061 KW. Rotavirus vaccination would reduce the burden of the disease substantially and be a cost-effective strategy to prevent rotavirus diarrhea in Korea.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Kamel A. Samara ◽  
Hiba J. Barqawi ◽  
Basant H. Aboelsoud ◽  
Moza A. AlZaabi ◽  
Fay T. Alraddawi ◽  
...  

AbstractAnnually, 1.5 million cases of hepatitis A infection occur worldwide. The United Arab Emirates (U.A.E.) has seen a decrease in infection rates and seroprevalence coupled with an increase in the average age of infection. This study aimed to assess the U.A.E. society’s hepatitis A knowledge, and attitudes and vaccination practices, with the applicability of its introduction into the local immunization schedule. A self-administered, 50-item questionnaire was used to collect data from the four most populous cities in the U.A.E., between January and March 2020. A total of 458 responses were collected and analysed using IBM-SPSS-26, R-4.0.0 and Matplotlib-v3.2.1. Females had better attitudes (P = 0.036), practices (P < 0.0005), immunization schedule knowledge (AOR = 3.019; CI 1.482–6.678), and appreciation of the immunization schedule (AOR = 2.141; CI 1.310–3.499). A higher level of perceived knowledge was associated with an actual better knowledge (P < 0.0005), better practices (P = 0.011), and increased willingness to get vaccinated (AOR = 1.988; CI 1.032–3.828). Respondents were more likely to vaccinate their children against HAV if the vaccine were introduced into the National Immunization Program (P < 0.0005). Overall, disease knowledge was lacking but with positive attitudes and poor practices. There is high trust in the National Immunization Program and a potential for improving poor practices through local awareness campaigns.


2011 ◽  
Vol 7 (10) ◽  
pp. 1109-1111 ◽  
Author(s):  
Ramesh Verma ◽  
Pardeep Khanna ◽  
Mohan Bairwa ◽  
Suraj Chawla ◽  
Shankar Prinja ◽  
...  

2013 ◽  
Vol 9 (1) ◽  
pp. 112-114 ◽  
Author(s):  
Maziar Moradi-Lakeh ◽  
Abdoulreza Esteghamati

PEDIATRICS ◽  
1990 ◽  
Vol 85 (5) ◽  
pp. ii-ii
Author(s):  

The Section on Allergy and Immunology was one of the first sections formed (1948) within the American Academy of Pediatrics. It now has almost 600 members. Its objective is to improve the care of children with asthma, allergies, and immunologic disorders. The Section aims to serve as a major informational and educational resource for the 34 000 members of the American Academy of Pediatrics. The Section sponsors a 2-day scientific program and symposium at each Anual Meeting of the Academy; and, for the past several years, it has also presented a symposium at the Annual Meeting of the American Academy of Allergy and Immunology, as well as the annual "Synopsis Book." Other educational activities by the Section include publishing position papers (most recently, "Exercise and the Asthmatic Child"), assisting the National Asthma Education Task Force of the National Institutes of Health, and developing informational pamphlets for patients. In addition, the Section sponsors visiting professorship programs to medical schools which do not have a division of pediatric allergy and immunology. The membership of the Section on Allergy and Immunology consists of Fellows of the American Academy of Pediatrics who have been certified by the American Board of Pediatrics and by the American Board of Allergy and Immunology. Any and all qualified American Academy of Pediatrics Fellows are invited to apply for membership in the Section. If interested, please write to: DIRECTOR, DIVISION OF SECTIONS American Academy of Pediatrics 141 Northwest Point Blvd PO Box 927 Elk Grove Village, IL 60009-0927 The reviews contained in this 1988 to 1989 synopsis were written by 28 Fellows of the American Academy of Pediatrics Section on Allergy and Immunology and by 5 senior fellows in allergy and immunology who contributed reviews under the aegis of their mentors.


Sign in / Sign up

Export Citation Format

Share Document